title: Hyperoxia increases keratinocyte growth factor mRNA expression in neonatal rabbit lung.
abstract: Acute hyperoxic lung injury remains a major factor in the development of chronic lung disease in neonates. A critical step in the repair of acute lung injury is the proliferation of type II alveolar epithelial cells. Type II cell proliferation is stimulated by keratinocyte growth factor (KGF), an epithelial cell-specific mitogen. We sought to investigate KGF mRNA expression in relation to type II cell proliferation during hyperoxic lung injury. We studied a previously described newborn (NB) rabbit model of acute and chronic hyperoxic injury [C. T. D'Angio, J. N. Finkelstein, M. B. LoMonaco, A. Paxhia, S. A. Wright, R. B. Baggs, R. H. Notter, and R. M. Ryan. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L720-L730, 1997]. NB rabbits were placed in 100% O2 for 9 days and then recovered in 60% O2. RT-PCR was used to synthesize and amplify a 267-bp fragment of rabbit KGF cDNA from whole lung RNA. KGF mRNA expression was analyzed by ribonuclease protection assay, and mRNA abundance was quantified by phosphorimaging. Proliferating cell nuclear antigen immunohistochemistry was used on lung sections to identify proliferating cells. The rabbit partial cDNA sequenced was >95% homologous to human cDNA, and all amino acids were conserved. Whole lung KGF mRNA expression was increased 12-fold after 6 days of hyperoxia compared with control lungs, and remained increased throughout the 100% O2 exposure period. Proliferating cell nuclear antigen immunohistochemistry showed an increase in type II cell proliferation after 8-12 days of hyperoxia. NB rabbits exposed to hyperoxic injury exhibit increased whole lung KGF mRNA expression preceding type II cell proliferation. KGF may be an important mitogen in the regulation of alveolar epithelial repair after hyperoxic lung injury.
authors.affiliation: Department of Pediatrics, Strong Children's Research Center, University of Rochester, Rochester, New York 14642, USA.
authors.forename: L
authors.initials: L
authors.lastname: Charafeddine
authors.forename: C T
authors.initials: CT
authors.lastname: D'Angio
authors.forename: J L
authors.initials: JL
authors.lastname: Richards
authors.forename: B R
authors.initials: BR
authors.lastname: Stripp
authors.forename: J N
authors.initials: JN
authors.lastname: Finkelstein
authors.forename: C C
authors.initials: CC
authors.lastname: Orlowski
authors.forename: M B
authors.initials: MB
authors.lastname: LoMonaco
authors.forename: A
authors.initials: A
authors.lastname: Paxhia
authors.forename: R M
authors.initials: RM
authors.lastname: Ryan
mesh_terms: D000595:Amino Acid Sequence / Q000235:genetics; D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism*; D001483:Base Sequence / Q000235:genetics; D002455:Cell Division / Q000502:physiology; D018076:DNA, Complementary / Q000235:genetics; D004847:Epithelial Cells / Q000473:pathology; D051526:Fibroblast Growth Factor 10; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors; D006133:Growth Substances / Q000235:genetics*; D006801:Humans; D018496:Hyperoxia / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D008168:Lung / Q000378:metabolism* / Q000503:physiopathology; D008969:Molecular Sequence Data; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000473:pathology; D012333:RNA, Messenger / Q000378:metabolism*; D011817:Rabbits; D014945:Wound Healing / Q000502:physiology
chemical_list: D018076:DNA, Complementary; C496453:FGF7 protein, human; D051526:Fibroblast Growth Factor 10; D006133:Growth Substances; D018809:Proliferating Cell Nuclear Antigen; D012333:RNA, Messenger; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors